Ultravate Cream

DRUG3 trials

Sponsors

Bausch Health Americas, Inc.

Conditions

Psoriasis

Phase 1

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

CompletedNCT03058744

Bausch Health Americas, Inc.Psoriasis

Start: 2015-04-30End: 2017-01-31Updated: 2017-06-09

Phase 2

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

CompletedNCT02785185

Bausch Health Americas, Inc.Psoriasis

Start: 2016-06-30End: 2017-01-31Updated: 2020-08-27

Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

CompletedNCT02785172

Bausch Health Americas, Inc.Psoriasis

Start: 2016-04-30End: 2017-01-31Updated: 2020-08-20

Related Papers

A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis

Journal of Dermatological Treatment2018-09-127 citations